Patents expiring in 2028

US 7411067

Crystalline forms of gatifloxacin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410978

Once daily dosage forms of trospium

Supernus Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410981

Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410958

Triterpene quaternary salts as biologically active surfactants

Regents of the University of Minnesota · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410781

IL-4/IL-13 specific polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410956

Caspase inhibitor prodrugs

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410771

Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410776

Polypeptides, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410950

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410363

Electrical connector having compliant biasing device

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410641

Antibodies to insulin/IGF/relaxin family polypeptides

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2677623

FORME PHARMACEUTIQUE CONTENANT DEUX OU DAVANTAGE DE PRINCIPES ACTIFS PHARMACEUTIQUES SOUS DES FORMES PHYSIQUES DIFFERENTES

ALPHAPHARM PTY LTD [AU] · Granted Thu Aug 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414046

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413538

Epitopes formed by non-covalent association of conjugates

Mozaic Discovery Limited · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413754

Use of extracts of the genus Cimicifugaas organoselective medicines for treating diseases of the genitourinary system caused by sex hormones

Bionorica AG · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413781

Gels for encapsulation of biological materials

The Board of Regents of the University of Texas System · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413864

Treating cancer using a telomerase vaccine

The Regents of the University of Colorado · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414035

hKIS composition and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414037

Hydrazide-containing CFTR inhibitor compounds and uses thereof

The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414140

Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413873

Method of detection and treatment of colon cancer

The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413870

SAK: modulation of cellular proliferation for treatment of cancer

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414039

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417070

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417136

Nucleic acid vaccines for prevention of flavivirus infection

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7416724

Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417113

PSCA: prostate stem cell antigen and uses thereof

The Regents of the University of California · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7416741

Copper lowering treatment of inflammatory and fibrotic diseases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417059

Substituted aromatic-ring compounds, process for producing the same and use

Takeda Pharmaceutical Company Limited · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417037

Compositions and methods of treatment for inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7416878

Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417134

IL-1 receptor based cytokine traps and method of using

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417029

Prodrug of an ice inhibitor

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417044

Tadalafil having a large particle size and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7417165

Crystalline forms of pregabalin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 1959855

BEHANDLUNG VON BENIGNER PROSTATAHYPERPLASIE MIT EINEM FOTOSENSIBILISATOR UND LASERABLATION

CERAMOPTEC GMBH [DE] · Granted Wed Aug 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419973

Phosphonocephem compound

Takeda Pharmaceutical Company Limited · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7420045

IAPs associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7420084

Polymorphic forms of nateglinide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7420100

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7420030

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419600

Method for purifying a branched water-soluble polymer

Nektar Therapeutics AL, Corporation · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419683

Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419962

3,6-bicyclolides

Enanta Pharmaceuticals, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419967

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419989

Indazole-carboxamide compounds

Theravance, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7419983

Gonadotropin-releasing hormone receptor antagonists and methods related thereto

Neurocrine Biosciences, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)